Search Videos and More
Video
Narjust Florez, MD Discusses International Medical Graduate Challenges
1 out of 4 doctors in the United States graduated from international medical schools, yet according to a study presented at ASCO24, these doctors remain victims of discrimination at frequent rates.
Video
Ana Garrido-Castro, MD Discusses SACI-IO HR+
Antibody-drug conjugate plus a checkpoint inhibitor shows a trend toward improved survival in PD-L1-positive hormone receptor-positive, HER2-negative breast cancer.
Video
Toni Choueiri, MD Discusses Kidney Cancer JAVELIN 101
Kidney cancer research at ASCO24: Final analysis in JAVELIN Renal 101 trial confirms the efficacy and manageable safety profile of avelumab plus axitinib versus sunitinib in patients with advanced kidney cancer. Dana-Farber's Toni Choueiri, MD, explains more.
Video
Toni Choueiri, MD Provides Kidney Cancer CLEAR Trial biomarker analysis
Biomarker analysis in the phase 3 CLEAR trial shows biomarkers don't impact the superiority of lenvatinib plus pembrolizumab versus sunitinib as a first-line therapy in patients diagnosed with advanced kidney cancer.
Video
Kimia Sorouri, MD, MPH Discusses Fertility and Breast Cancer
Study shows most women attempting to conceive after breast cancer treatment can do so and give birth. Dana-Farber's Kimia Sorouri, MD, MPH, discusses the first prospective study with more than 10 years of follow-up that also accounts for conception attempts.
News
Study Identifies Novel Target for Pediatric Neuroblastoma
Researchers at Dana-Farber Cancer Institute have identified a protein complex that is required for the growth of a high-risk form of childhood brain cancer called MYCN-amplified neuroblastoma.
News
Research Provides New Insights Into ‘Infernal’ Mode of Cell Death
A group of scientists at Dana-Farber have trained their attention on an ancient family of proteins, called gasdermins, that punch holes, or pores, in the cell membrane during pyroptosis.
News
Telehealth Can Significantly Reduce Greenhouse Gas Emissions Associated with Cancer Care, Study Finds
Telemedicine visits for cancer care may not only be more convenient and easier to schedule than in-person appointments, they're also better for the planet, new research by Dana-Farber Cancer Institute scientists shows.
Symposium
AACR 2024 Highlights
Review presentations and information shared by Dana-Farber physician-scientists at the 2024 American Association of Cancer Research (AACR) Annual Meeting held April 5-10, San Diego, CA.
News
Science Behind Targeted Drug for Pediatric Brain Cancer Has Dana-Farber Roots
Two separate research teams had discovered a genetic driver for the most common of childhood brain tumors called pediatric low-grade glioma.
News
Dana-Farber Researchers Discover New Target for Potential Leukemia Therapy
A team of Dana-Farber Cancer Institute investigators discovered that a subset of myeloid and lymphoid leukemias depend on a molecular complex called PI3Kgamma for survival.
News
Most Young Women Treated For Breast Cancer Can Have Children, Study Shows
In a study of nearly 200 young women who have survived breast cancer, most of those who tried to conceive were able to become pregnant and give birth.